Figure 1
Overview of the selection of the study population. CHD-APAH, pulmonary arterial hypertension (PAH) associated with congential heart disease; CTD-APAH, PAH associated with connective tissue disease without interstitial lung disease; FPAH, familial PAH; IPAH, idiopathic PAH; PH, pulmonary hypertension; PVOD, pulmonary veno-occlusive disease; RHC, right heart catheterization; SSc-APAH, PAH associated with systemic sclerosis without interstitial lung disease.

Overview of the selection of the study population. CHD-APAH, pulmonary arterial hypertension (PAH) associated with congential heart disease; CTD-APAH, PAH associated with connective tissue disease without interstitial lung disease; FPAH, familial PAH; IPAH, idiopathic PAH; PH, pulmonary hypertension; PVOD, pulmonary veno-occlusive disease; RHC, right heart catheterization; SSc-APAH, PAH associated with systemic sclerosis without interstitial lung disease.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close